Ledger.Open graph →
SEC Form D · filed December 15, 2015

CONSTELLATION PHARMACEUTICALS INC

Offering
$55.8M
Sold
$55.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Michael R. Cooper · Cambridge, MAExecMark A. Goldsmith · Cambridge, MADirectorAnthony A. Evnin · Cambridge, MADirectorMatthias E. Jaffe · Cambridge, MAExecTom A. Maniatis · Cambridge, MADirectorJames E. Audia · Cambridge, MAExecRobert A. Tepper · Cambridge, MADirectorKeith Dionne · Cambridge, MAExec · DirectorDavid A. Goeddel · Cambridge, MADirectorAQR Investment Fund GP, LLC · Greenwich, CTExec · DirectorStephen C. O'Meara · Dania Beach, FLExecWayne S. Kirk · Vancouver, British Columbia, CanadaExecMark S. Fields · Vancouver, British Columbia, CanadaDirectorAmol Desai · Lafayette, LADirectorKenneth Towers · Camana Bay, Grand Cayman, Cayman IslandsExecJonathan C. Trousdale · Dania Beach, FLDirectorJayendra E. Das · BOSTON, MAExec · DirectorJoseph Kinsella · BOSTON, MADirectorAriel E. Tseitlin · BOSTON, MAExecGreg Dracon · BOSTON, MAExec · DirectorDale A. Buckwalter · PITTSBURGH, PAExecRobert C. Mcguire · PITTSBURGH, PADirectorMichael T. Puckett · New Orleans, LADirectorJeffrey S. Muir · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗